3 days ago Nasdaq Biotechnology Index advanced index charts by� Nasdaq Biotechnology Index historial options data by MarketWatch. View NBI � IBB | A complete iShares Nasdaq Biotechnology ETF exchange traded fund overview by MarketWatch. View the latest ETF prices and news for better ETF� The Fund seeks to track the investment results of the NASDAQ Biotechnology Index composed of biotechnology and pharmaceutical equities listed on the�
NBI | A complete Nasdaq Biotechnology Index index overview by MarketWatch. View stock market news, stock market data and trading information.
Nasdaq Biotechnology Index historial options data by MarketWatch. View NBI � IBB | A complete iShares Nasdaq Biotechnology ETF exchange traded fund overview by MarketWatch. View the latest ETF prices and news for better ETF� The Fund seeks to track the investment results of the NASDAQ Biotechnology Index composed of biotechnology and pharmaceutical equities listed on the� 3 days ago Key U.S., Last, Chg, Chg %. Dow Jones Industrial Average, 19,173.98, -913.21, - 4.55%. NASDAQ Composite Index, 6,879.52, -271.06, -3.79%. Viela Bio Inc. 32.00, -12.19, -27.59%� NBI, Nasdaq Biotechnology Index, 3,085, 3/20/2020, 5:16 PM, -89.58, -2.82%. OSX, PHLX Oil Service Index, 22.88, 3/20/2020, 5:16 PM, +0.1612, +0.71%.
3 days ago Key U.S., Last, Chg, Chg %. Dow Jones Industrial Average, 19,173.98, -913.21, - 4.55%. NASDAQ Composite Index, 6,879.52, -271.06, -3.79%.
BIB | A complete ProShares Ultra Nasdaq Biotechnology exchange traded fund overview by MarketWatch. seeks daily investment results, before fees and expenses, that correspond to two times the return of the Nasdaq Biotechnology Index.
Viela Bio Inc. 32.00, -12.19, -27.59%�
US Indexes. Dow25,864.780.98%256.50 � S&P 5002,972.371.71%51.57 � Nasdaq8,575.621.87%162.98. US Index Futures. Dow Futures25,779.000.04% 10.00.
Viela Bio Inc. 32.00, -12.19, -27.59%�
BIB | A complete ProShares Ultra Nasdaq Biotechnology exchange traded fund overview by MarketWatch. seeks daily investment results, before fees and expenses, that correspond to two times the return of the Nasdaq Biotechnology Index.